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Abstract 
 
Recent evidence suggests there is a role for the dental team, particularly dentists in offering 
chairside HIV screening to patients during the dental appointment. HIV is no longer a death 
sentence with early diagnosis and effective treatment contributing a good prognosis. 
Despite the availability of both venipuncture diagnostic and rapid saliva / finger prick 
screening  tests for HIV infection, 25% of people living with HIV in the United Kingdom are 
undiagnosed and remain a risk of transmitting their infection if having unprotected sex. This 
paper highlights the international evidence that supports dentists’ willingness to conduct 
HIV screening and dental patient acceptance, and explores whether this is an opportunity or 
a step too far.  
 
 
 
In Brief: 
 
• Rapid HIV screening represents an opportunity for the dentist to expand their role in 
diagnosis and prevention. 
• Additional training, logistical and financial support may be needed to enable dentists 
and other members of the dental team to fulfil this role. 
• Further research is needed to explore whether UK patients are prepared to accept 
HIV screening from the dentist and to investigate the barriers and facilitators to 
development and implementation of this service.  
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Introduction 
Tuesday 1st December 2015 was World AIDS Day – a time for us all to reflect on the action 
still needed to combat the Human Immunodeficiency Virus (HIV) epidemic. It has been over 
30 years since the first cases of HIV were diagnosed. The United Nations (UN) estimates that 
globally 36.9 million people are now living with HIV.  In 2014, over two million individuals 
became newly infected and 1.2 million people died from Acquired Immune Deficiency 
Syndrome (AIDS) related illnesses. Rates of HIV infection vary considerably around the world 
with 95% of infections occurring in developing countries.1  
 
However, despite the magnitude of this global public health problem there are signs of 
optimism. Across the world 15 million people living with HIV are now accessing 
antiretroviral therapy (ART). Encouragingly, 73% of pregnant women living with HIV had 
access to ART to prevent mother-to-child transmission and this has resulted in a 58% 
reduction in new HIV infections from 2000-2014. New rates of HIV infection have fallen by 
35% across the world since 2000 and there has been a 42% reduction in AIDS-related deaths 
since the peak in 2004.1  
 
An HIV diagnosis is now no longer an automatic death sentence. Developments in ART and 
care have dramatically improved the prognosis of a person diagnosed with HIV infection. 
Most people diagnosed with HIV infection can now expect to live a long and healthy life. 
Indeed HIV infection is now considered a long-term condition, similar in many respects to 
other chronic conditions such as diabetes. Recent guidelines from the World Health 
Organisation set a “treat all” recommendation, removing all limitations on eligibility for ART 
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among people living with HIV – all populations and age groups are now eligible for 
treatment.2  
 
The other key element in HIV prevention strategies is improving the availability and access 
to HIV screening. Early diagnosis dramatically improves health outcomes of the individuals 
infected and is an important means of reducing future infections. There have been major 
improvements in HIV screening and testing technology  which now makes accurate test 
results much easier and quicker. In the United Kingdom (UK) HIV screening is now offered in 
a wide range of settings including antenatal services, sexual health clinics, general 
practitioners (GP) practices and pharmacists, and self-testing kits are available from the 
internet and in pharmacies.  
 
The aims of this paper are to review developments in HIV prevention and treatment and to 
discuss dentists’ potential to become more involved in offering HIV screening. First we will 
summarize UK HIV data and highlight evidence underpinning current preventive strategies 
to combat this infectious condition. Details of HIV diagnostics available in the UK will then 
be presented. Studies from across the world assessing dentists’ and dental patients’ 
willingness and attitudes towards HIV screening will also be summarized. Finally, we will 
consider opportunities for UK dentists to offer HIV screening and the barriers to this is 
agenda being taken forward. 
 
Epidemiology of HIV in the UK 
In 2013 there was an estimated 107,800 (95% confidence interval 101,600-115,800) people 
living with HIV in the UK. Around 25% of those are undiagnosed and remain a risk of 
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transmitting their infection if having unprotected sex. It is estimated that 90% of HIV 
infections are contracted through unsafe sexual contact. The overall prevalence was 2.8 per 
1,000 population aged 15-59 years, with a 2:1 male to female ratio (1.9 per 1,000 women 
and 3.7 per 1,000 men).3  
 
Incidence trends are shown in Figure 1. There were 6,000 people (4,480 men and 1,520 
women) newly diagnosed with HIV in the UK in 2013, slightly down from 6,250 diagnoses in 
the previous year. These case numbers equate to an estimated new HIV diagnosis rate of 
approximately 1.0 per 10,000 population (1.4 per 10,000 men and 0.46 per 10,000 women). 
New diagnoses have been declining since they peaked in 2005 (at 7,890), largely due to a 
decrease in the number of diagnoses reported among heterosexuals born in high HIV 
prevalence countries (particularly sub-Saharan Africa).3  
 
There are wide inequalities in the burden of HIV. In 2013, the prevalence of HIV was around 
30 times higher among men who have sex with men (MSM) and among Black-African men 
and women compared to the general population in the UK.4 Approximately 75% of HIV 
infections in the UK are amongst these two groups. However, HIV prevalence is also highest 
in the most deprived communities – despite similar proportions of those from offered and 
accepting HIV screening tests being similar in different socioeconomic groups/areas of 
socioeconomic deprivation. . Health inequalities also manifest in late diagnosis particularly 
among older people and those from black and minority ethnic groups – the latter partly 
explained by the high proportion acquiring the infection abroad.3 
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HIV prevention strategies  
HIV is no longer the death sentence associated with the UK’s 1980s tombstone advertising 
campaign.5 People living with HIV have near normal life expectancy and better clinical 
outcomes if they are diagnosed early. Early diagnosis also leads to earlier access to effective 
treatment and reduces the risk of onward transmission. A meta-analysis of published 
studies showed that people who know their HIV status reduce their high-risk sexual 
behaviours by 68%.6  
 
On World AIDS Day 2014 the UN Joint Programme on HIV/AIDS (UNAIDS) launched its “Fast-
Track” strategy which aims to end the world AIDS epidemic by 2020. In it they set out the 
“90-90-90 approach by 2020” with targets of: 90% of people living with HIV knowing their 
HIV status; 90% of people who know their HIV-positive status on treatment; and 90% of 
people on treatment with suppressed viral loads.1  
 
The UK has adopted the “Fast-Track” strategy and UK HIV preventive policies aim to reduce 
the number of HIV transmissions via increasing prevention, increasing early diagnosis and 
improving the treatment and care of those living with the virus.7,8 The only routine HIV 
screening testing that takes place out with sexual health services is antenatal screening for 
pregnant women. There are efforts to expand screening to other healthcare settings 
including: GPs, hospitals, and pharmacies, however, thus far dental practices have not really 
been considered.  
In addition to saving lives, early detection of HIV has considerable potential cost savings. 
Public Health England estimated lifetime treatment costs to the NHS associated with HIV 
infection of £280,000 to £360,000, and estimated that if all the newly diagnosed cases in 
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2010 had been prevented, £1.0 to £1.3 billion lifetime NHS treatment (not including wider 
societal costs) would have been saved. 9 Moreover, HIV care costs are substantially more if 
patients are diagnosed late. 10 
 
Overview of HIV diagnostics 
Rapid HIV screening works by seizing either antibodies or antigen on a surface and then 
attaching molecules to them that are made visible for individuals or clinicians to see. This 
process occurs in approximately 20 minutes. All rapid screening tests have what is known as 
a window period. A window period is the time during which infection is undetectable. Most, 
recent fourth generation rapid tests have a window period of one month. When test results 
are read, they can be found to be reactive (i.e., preliminary positive) or negative. All reactive 
test results should be followed by a confirmatory test.  A confirmatory test is also known as 
a Western blot test, detects HIV antibodies in the blood sample. There are nine rapid HIV 
tests available in the UK. All manufacturers report sensitivity (true positive rate) and 
specificity (true negative rate) above 99%.11  See Table 1 for approved HIV tests in the UK. 
The first HIV self-test kit went on sale in the UK in April 2014. This can be bought from 
Biosure (www.hivselftest.co.uk). The Biosure test claims to be 99.7% accurate if used as 
instructed.  
  
International studies on the role of dental professionals in HIV screening 
To date, there have been few studies on dentists’ attitudes toward HIV testing in the dental 
setting, and none of these studies were conducted in the UK. Although most were cross-
sectional surveys, one was mixed methods and included a qualitative component (focus 
groups).  A summary of these six studies can be found in Table 2. Willingness to offer rapid 
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HIV screening varied (Australia: 61.5%, United States: 56.7%, Vietnam: 90%). Dentist 
attitudes as to whether rapid HIV screening is needed in the oral health setting also varied 
(China: 91.2%, India: 79.9%, Korea: 88%, Vietnam: focus group theme). Finally, the biggest 
barriers for implementing rapid HIV screening in the oral health setting included: lack of 
education for oral health provider on test (Australia, China, Korea), lack of knowledge of 
how to administer test (India, Vietnam), and subjective norms of patients and colleagues 
(United States). 12, 13, 14, 15, 16, 17 
 
Since the United States and Australia are most similar to the UK, we have highlighted 
additional data here. Among the 532 Australian dentists surveyed, most (78.1%) were 
uncomfortable advising a patient of a reactive screening result.  Additionally, those who 
thought rapid HIV screening was needed in the dental setting were younger (P=0.0008), had 
fewer years of experience (P=0.002), worked in a private health fund run clinic (P=0.04), 
treated few people living with HIV in the past year (P=0.04) and had a lower HIV knowledge 
score (P=0.004). More than half (51.1%) of participants preferred saliva-based testing, as 
opposed to blood (9.6%). Almost half (45.9%) felt that HIV testing was necessary before 
invasive procedures, but 37.8% did not think it was necessary at all. The majority of 
participants (88.7%) felt that only dentists should conduct rapid HIV screening, compared to 
oral health therapists and hygienists (18.6%) and dental nurses (13.3%). Before screening 
could be implemented in the oral health setting, participants felt that their lack of education 
relating to HIV screening (44.8%) and not being comfortable reporting a reactive test result 
(35%) needed to be addressed.15 
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Among the 1,802 American dentists surveyed about their willingness to provide expanded 
HIV screening in oral health settings, only 14 were currently offered rapid HIV screening. 
Clinical knowledge and previous training in HIV disease were not associated with their 
willingness to offer rapid HIV screening; however, they were associated with acceptance of 
the screening as part of the dentists’ professional role. Additionally, dentists who believed 
rapid HIV screening was of public health significance were more likely to report willingness 
to conduct it. Finally, willingness to offer rapid HIV screening and accept it as a professional 
duty was correlated with agreement  that patients would accept screening in the oral health 
setting and both colleagues’ and patients’ perceptions of them would improve.13   
 
Few studies have examined patient attitudes of receiving rapid HIV screening in the oral 
health setting. Of 150 dental patients from Kansas City, U.S., 73% reported willingness to 
take a free HIV screening during their dental visit. Patients with a history of multiple prior 
screening tests for HIV were more likely to agree to oral rapid HIV screening in the dental 
clinic.18 In another study of 470 dental patients in New Jersey, U.S. (288 university dental 
clinic patients and 182 private dental clinic patients) examining attitudes toward chairside 
medical screenings, 80% and 55% of respondents, respectively, were in favour of being 
screened for HIV during a dental visit.19 Several patient studies have been conducted in New 
York City (NYC), one of the HIV epicenters. In a public hospital demonstration project 97.6% 
of dental patients who were approached agreed to be tested.20 In another study at a NYC-
based dental school that examined patients’ agreement to participate in oral rapid HIV 
screening, only 8.2% of the patients contacted by the clinic administration staff completed 
testing. However, when approached by a faculty member or dental student during the 
dental visit admission and tested during the dental visit, 88.2% completed testing.21 In a 
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similar study of 436 patients across three university-based dental hygiene clinics, over half 
(72.2%) indicated acceptability to HIV screening in a dental hygiene clinic, with 85.3% 
choosing oral RHT. Over 30% indicated that they were willing to receive the RHT at no 
cost.22 In another survey of 521 patients attending private and public dental clinics in 
Sydney, Australia, 82% were willing to have a rapid HIV screening in the oral health setting, 
76.1% preferred the oral screening, and 74.9% were not willing to pay for the test.23 In a 
dental patient study in India, acceptance of HIV screening in the dental setting was high 
(71.0% clinic and 70.5% private).24 Finally, screening implementation issues have not gone 
unnoticed. In a qualitative study of 19 dental patients, a number of logistical issues related 
to implementation of oral rapid HIV screening were found and included: getting positive test 
results; need for professional counseling and linkage to care for HIV positive patients, 
providing HIV prevention educational materials, and the need for privacy.25 
 
 
HIV screening in dental settings – an opportunity or a step too far? 
Significant progress has been made in tackling the HIV epidemic in the UK. However much 
still needs to be done as there are over 100,000 people living with HIV and rates of new 
infections remain stubbornly high. Dramatic advances in treatment have radically changed 
the nature of this disease. Now a central plank of HIV prevention national policy is for 
people to be tested early for the infection and to begin ART as soon as possible. In this 
article we have presented an update on developments in HIV and raise the question of 
whether dentists in the UK should be offering rapid HIV screening. Some may think this is 
well beyond the role of UK dentists, whereas others may see an opportunity ahead.  
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As is the case with other areas of prevention such as smoking cessation and alcohol advice, 
there is strong justification for dentists to extend their clinical preventive role to other 
relevant areas. A significant proportion of the UK population are regularly seen by dentists – 
nearly 30 million adults (56% of the population) were seen by a dentist in the last 24 
months.26 Dental staff are uniquely placed to provide preventive support as they regularly 
reach parts of the population that other NHS services cannot. This is particularly true for 
young and middle aged adults who may have limited contact with primary medical care but 
who are still at a stage of life where interventions to change behaviours will have an impact. 
Dentists are highly trained professional health care workers and have training and 
experience to present difficult news to patients and ensure appropriate treatment or 
referral as for example is the case with urgent referral for suspected oral cancer. 
Undertaking HIV screening test in dental practices could be considered a safe healthcare 
environment where ongoing referral to relevant services could be secured, while self-testing 
at home could be more isolated and unsupported, and while there may be greater 
reluctance to attend sexual health clinics. The oral (saliva) HIV screening test is very much in 
keeping with the practice of dentistry and therefore may seem of direct relevance to 
patients. Dentists were previously at the forefront of the early detection of HIV/AIDS 
particularly with the prominence of oral conditions – including candida, oral hairy 
leukoplakia, and Kaposi sarcoma.27 This potential new role in HIV screening may therefore 
be appropriate.  
 
However, a range of barriers need addressing before this becomes a reality. Lack of training 
and knowledge, limited time and concerns over costs (including the questions: who would 
pay for it?, would patients pay for it?), perceived relevance of HIV testing to dentistry, 
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concerns over upsetting or alienating patients, and fears over the sensitivity of discussing 
sexual health matters are all major barriers that need to be overcome. In addition special 
contractual arrangements may need to be administered for this issue to be adopted in busy 
NHS practices, and monitoring of equity of access and uptake of screening in dental settings. 
Some of these same issues – particularly in relation to the sensitive topic - were raised and 
overcome during the Human Papilloma Virus (HPV) Oral Prevalence Study in Scotland 
(HOPSCOTCH) feasibility study.28 
 
People living with HIV often experience stigma and discrimination based upon fear and 
ignorance. Many people living with HIV also face prejudice related to their sexuality and/or 
ethnicity. If dentists are to become involved in offering HIV screening, patients would need 
to have complete confidence in the confidentiality and respect they will receive from their 
dental providers. Staff training would therefore be essential for all members of the dental 
team. At present no research has been published on the attitudes and knowledge of dental 
staff in this area. Research is therefore needed to explore how dental professionals and 
teams as well as dental patients would view the prospect of dentists offering HIV screening. 
This information would help design tailored training courses for dental staff.  
 
Moreover, if dental practices became involved in this area, it would be essential to have 
local protocols in place and information available on sexual health services to refer patients 
for definitive testing, support, and ongoing care as required. Dentists and their teams would 
also need to be able access relevant support and advice from experts in HIV as required.  
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It is highly unlikely that dentists would offer universal HIV screening to all their patients. A 
targeted approach would seem more appropriate but the logistics of how this would be 
offered requires some thought to avoid prejudicial practices. One option would be to inform 
all adult patients that the practice offers HIV screening, and then for the patients to request 
more information about the testing procedures. Or alternatively, as Public Health England 
propose for commissioning HIV screening in general (dental practices are not thus far 
considered) to potentially to focus / commission HIV screening services in dental practices 
working in areas or communities with known higher diagnosed prevalence (at least 2.0 per 
1,000 population). 29, 30 
 
Conclusions 
At the emergence of the HIV / AIDS epidemic in the 1980s, dentists were at the forefront of 
early detection screening for oral lesions associated with HIV infection and AIDS.31  
Three decades on, great progress has been made in diagnosis, treatment, and prognosis. 
Dentists and other members of the dental team may still have a role in helping to identify 
new cases of HIV with the goal of improving health outcomes, addressing health 
inequalities, and improving the quality and quantity of life.32  A quarter of those infected 
with HIV do not know they have it, are therefore not in treatment and remain at risk of 
transmitting the infection. There is a global and UK call to normalise and expand the 
provision of routine HIV screening and testing. In the United States they are further ahead 
with this agenda exemplified by the “know your status” preventive campaign 
(http://www.knowyourstatustoday.com/). In our view dentists can have a potential role in 
normalising and delivering HIV screening – and in working towards ending the HIV epidemic.  
 
14 
 
References 
1. UNAIDS 2014. Online information available at 
http://www.unaids.org/en/resources/documents/2014/ (accessed September 2015). 
 
2. World Health Organisation. Guideline on when to start antiretroviral therapy and on 
pre-exposure prophylaxis for HIV. Geneva: WHO, 2015. Online information available 
at http://www.who.int/hiv/pub/guidelines/earlyrelease-arv/en/ (accessed October 
2015). 
 
3. Yin Z, Brown A E, Hughes G, et al. HIV in the United Kingdom 2014 Report: data to 
end 2013. London: Public Health England, 2014. 
 
4. Fakoya I, Reynolds R, Caswell G, Shiripinda I. Barriers to HIV testing for migrant black 
Africans in Western Europe. HIV Med 2008; 9: Suppl 2:23-5. 
 
5. HM Government. AIDS Don’t Die of Ignorance [YouTube]. 1986. Online information 
available at https://www.youtube.com/watch?v=9SqRNUUOk7s (accessed 
September 2015). 
 
6. Marks G, Crepaz N, Senterfitt J W, Janssen R S. Meta-analysis of high-risk sexual 
behaviour in persons aware and unaware they are infected with HIV in the United 
States. JAIDS 2005; 39: 446-453. 
 
7. Westrop S J, McNeal F, Anderson J, Gill N, Nardone A. HIV Testing and Self-Testing. 
London: Public Health England, 2014. 
 
8. Scottish Government. Sexual Health and Blood Borne Virus Framework. Scotland: 
Healthier Scotland, 2011. Online information available at 
http://www.gov.scot/Publications/2011/08/24085708/0 (accessed September 
2015). 
 
9. Health Protection Agency. Evidence and resources to commission expanded HIV 
testing in priority medical services in high prevalence areas. Colindale, 2011. Online 
information available at 
http://www.boltonshealthmatters.org/sites/default/files/Evidence%20to%20commi
ssion%20expanded%20HIV%20testing.pdf (accessed October 2015). 
 
10. National Institute of Clinical Excellence. Increasing the uptake of HIV testing among 
black Africans in England and increasing the uptake of HIV testing among men who 
have sex with men - Costing report – implementing NICE guidance. National Institute 
of Clinical Excellence, London, 2011. Online information available at 
https://www.nice.org.uk/guidance/ph33 (accessed October 2015). 
 
15 
 
11. National AIDS Manual - AIDSMAP. HIV testing. 2015. Online information available at 
http://www.aidsmap.com/HIV-testing/page/1320696/ (accessed September 2015). 
12. Wang L, Santella A J, Huang R, et al. Knowledge of HIV and willingness to conduct 
oral rapid HIV testing among dentists in Xi’an China. PLoS ONE 2015; 10: e0119274.  
 
13. Pollack H A, Pereyra M, Parish C L, et al. Dentists’ willingness to provide expanded 
HIV screening in oral health care settings: Results from a nationally representative 
survey. Am J Public Health 2014; 104: 872-880.  
 
14. Park J C, Choi S H, Kim Y T, et al. Knowledge and attitudes of Korean dentists towards 
human immunodeficiency virus/acquired immune deficiency syndrome. J 
Periodontal Implant Sci 2011; 41: 3–9.  
 
15. Santella A J, Schlub T E, Schifter M, Tolani M, Hillman R J. Australian dentists’ 
perspectives on rapid HIV testing (RHT). Aust Dent J 2015; doi: 10.1111/adj.12371 
 
16. Ngaihte P C, Santella A J, Watt R G, Saxena S R, Vatsyayan V. Envisioning the role of 
Indian dentists in conducting rapid HIV testing for early detection of HIV. Indian J 
Public Health. Forthcoming.  
 
17.  Santella A J, Nguyen T A, Schifter M, Hillman R J. Vietnamese dentists’ attitudes and 
willingness to conduct saliva-based HIV testing, J Dent Res 2015; 94: 3907 
 
18. Dietz C, Ablah E, Reznik D, Robbins D. Patients’ attitudes about rapid oral HIV 
screening in an urban, free dental clinic. AIDS Patient Care STDS 2008; 22: 205–212. 
 
19. Greenberg B L, Kantor M L, Jiang S S, Glick M. Patients’ attitudes toward screening 
for medical conditions in a dental setting. J Public Health Dent 2012; 72: 28–35. 
 
20. Blackstock O J, King J R, Mason R D, Lee C C, Mannheimer S B. Evaluation of a rapid 
HIV testing initiative in an urban, hospital-based dental clinic. AIDS Patient Care STDS 
2010; 24: 781–785. 
 
21. Nassry D, Phelan J, Ghookasian M, et al. Patient and provider acceptance of oral HIV 
screening in a dental school setting. J Dent Educ 2012; 76: 1150–1155. 
 
22. Furnari W, Davide S, Leuwaisee P, Cortell M, Santella A J, Krishnamachari B. Dental 
hygiene patients' willingness to undergo HIV testing. .Paper presented at: The 
American Dental Hygiene Association Annual Meeting, 2014 June, Las Vegas, 
Nevada.   
 
23. Santella A J, Schlub T E, Schifter M, et al. (2014, July). Willingness of dental patients 
to undergo HIV testing in the dental setting. Paper presented at: The International 
AIDS Conference; 2014 July; Melbourne, Australia. 
 
16 
 
24. Sansare K, Raghav M, Kasbe A, et al. Indian patients' attitudes towards chairside 
screening in a dental setting for medical conditions. Int Dent J 2015; 65: 269-76.  
 
25. VanDevanter N, Combellick J, Hutchinson M K, Phelan J, Malamud D, Shelley D. A 
qualitative study of patients’ attitudes toward HIV testing in the dental setting. Nurs 
Res Pract 2012; 2012: 1-6.  
 
26. Health and Social Care Information Centre. Number of people seen by an NHS dentist 
nearing 30 million. Online information available at 
http://www.hscic.gov.uk/article/4993/Number-of-people-seen-by-an-NHS-dentist-
nearing-30-million (accessed September 2015) 
 
27. Greenspan D, Greenspan J S, Schiodt M, Pindborg, J J. AIDS and the mouth. 
Copenhagen: Munksgaard, 1990. 
 
28. Conway D I, Bagg J, Clarkson J, et al. Human Papilloma Virus (HPV) Oral Prevalence in 
Scotland – HOPSCOTCH: Feasibility study. Scotland: Scottish Government Health 
Directorates Chief Scientist Office, 2015. Online information available at 
http://www.cso.scot.nhs.uk/wp-content/uploads/CZH_4_917.pdf (accessed October 
2015). 
 
29. Public Health England. Commissioning HIV Testing Services. PHE, London October 
2014. Online information available at 
http://www.nat.org.uk/media/Files/Publications/Nov_2013_Toolkit.pdf (accessed 
October 2015) 
 
30. Public Health England.  Addressing Late HIV Diagnosis through Screening and 
Testing: An Evidence Summary. PHE, London 2014. Online information available at 
http://webarchive.nationalarchives.gov.uk/20140722091854/http://www.hpa.org.u
k/webc/HPAwebFile/HPAweb_C/1317141126407 (accessed October 2015) 
 
31. Silverman S Jr, Migliorati C A, Lozada-Nur F, Greenspan D, Conant M A. Oral findings 
in people with or at high risk for AIDS: a study of 375 homosexual males. J Am Dent 
Assoc 1986; 112: 187-92 
 
32. Reznik D A, Screening for infectious diseases in the dental setting. Dent Clin North 
Am 2012; 56: 809-18.  
 
